Absci (ABSI) Current Assets (2020 - 2026)
Absci's (ABSI) quarterly Current Assets came in at $132.0 million in Q1 2026, down 15.39% year-on-year from $156.0 million in Q1 2025, and down 11.77% quarter-over-quarter from $149.6 million in Q4 2025.
Absci (ABSI) Current Assets (2020 - 2026) Analysis & Trends
Absci has disclosed Current Assets across 7 years of filings, most recently posting $132.0 million for Q1 2026.
- Current Assets for Q1 2026 came in at $132.0 million, down 15.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $132.0 million (down 15.39% YoY), and the FY2025 annual result was $149.6 million, up 11.76% from the prior year.
- Current Assets came in at $132.0 million for Q1 2026 at Absci, down from $149.6 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $256.0 million in Q1 2022 to a low of $120.6 million in Q4 2023.
- The 5-year median for Current Assets is $156.0 million (2025), against an average of $166.0 million.
- Across the five-year window, Current Assets surged 102.76% in 2022 and plunged 35.47% in 2023, its largest moves.
- Absci's Current Assets stood at $186.9 million in 2022, then slumped by 35.47% to $120.6 million in 2023, then rose by 10.99% to $133.8 million in 2024, then grew by 11.76% to $149.6 million in 2025, then decreased by 11.77% to $132.0 million in 2026.
- The last three Current Assets figures came in at $132.0 million (Q1 2026), $149.6 million (Q4 2025), and $175.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 131.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 131.97 Mn |
| Dec 31, 2025 | 149.57 Mn |
| Sep 30, 2025 | 174.99 Mn |
| Jun 30, 2025 | 137.40 Mn |
| Mar 31, 2025 | 155.98 Mn |
| Dec 31, 2024 | 133.83 Mn |
| Sep 30, 2024 | 150.14 Mn |
| Jun 30, 2024 | 165.19 Mn |
| Mar 31, 2024 | 181.80 Mn |
| Dec 31, 2023 | 120.58 Mn |
| Sep 30, 2023 | 134.71 Mn |
| Jun 30, 2023 | 148.04 Mn |
| Mar 31, 2023 | 165.32 Mn |
| Dec 31, 2022 | 186.86 Mn |
| Sep 30, 2022 | 201.38 Mn |
| Jun 30, 2022 | 227.89 Mn |
| Mar 31, 2022 | 255.96 Mn |
| Dec 31, 2021 | 273.08 Mn |
| Sep 30, 2021 | 300.67 Mn |
| Jun 30, 2021 | 112.39 Mn |